Identify Promising Novel Leads: Integrated HTS platform powered by computational chemistry and AI/ML
High Throughput Screening (HTS) is one of the most powerful …
We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.
The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ...
Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.
Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.
High Throughput Screening (HTS) is one of the most powerful …
We are glad to show you the overview of Axcelead’s …
We would like to introduce one of our strengths, high-throughput …
Axcelead’s design-make-test-analysis cycle for bifunctional degrader allows rapid discovery promising …
Axcelead is capable of offering one-stop solution for molecular glue …
Safety-related drug attrition is still a major hurdle in the …
Axcelead is the first integrated drug discovery solutions provider in …
Drug discovery and development is a challenging and long process. …
How to identify and validate potential drug targets when looking …
In drug discovery, clinical candidate compounds are generated through a …